EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database

Jyotirmoy Sarker iD, Emir Carkovic, Karolina Ptaszek, Todd A Lee iD

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2024

DOI: 10.1002/phar.2920 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2024. Verfasst von Jyotirmoy Sarker und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Antiviral Agents, Adverse Drug Reaction Reporting Systems, United States Food and Drug Administration, Influenza, Human. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study Objective To determine whether there is a signal for gastrointestinal (GI) or intracranial (IC) hemorrhage associated with the use of antiviral medications for influenza in the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) database.

Design

Disproportionality analysis. Data Source The FAERS database was searched using OpenVigil 2.1 to identify GI and IC hemorrhage events reported between 2004 and 2022.

Measurements

Antiviral medications for influenza included the following: oseltamivir, zanamivir, peramivir, and baloxavir marboxil. Hemorrhage events were identified using Standardized Medical Dictionary for Regulatory Activities (MedDRA) Queries for GI and IC hemorrhages. Reporting odds ratios (RORs) were calculated to compare the occurrence of GI and IC hemorrhage events between antiviral drugs for influenza and (i) all other medications and (ii) antibiotics. RORs were also calculated for each of the individual antiviral medications. Main Results A total of 245 cases of GI hemorrhage and 23 cases of IC hemorrhage were identified in association with four antivirals. In comparison with all other drugs, the RORs of GI hemorrhage for oseltamivir, zanamivir, peramivir, baloxavir, and all antivirals combined were 1.17, 0.62, 4.44, 2.53, and 1.22, respectively, indicating potential variations in GI hemorrhage risk among the antivirals. In contrast, in comparison with all other drugs, the RORs of IC hemorrhage for oseltamivir (0.44), zanamivir (0.16), baloxavir (0.44), and all antivirals combined (0.41) were less than 1.0 which is consistent with no elevated risk of IC hemorrhage.

Conclusion

In this study, some signals for GI hemorrhage were observed, particularly for peramivir and baloxavir marboxil. Further investigation is warranted to better understand and evaluate the potential risks of GI hemorrhage associated with antiviral treatments for influenza.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsAdverse Drug Reaction Reporting SystemsUnited States Food and Drug AdministrationInfluenza, HumanGastrointestinal HemorrhageDatabases, FactualOseltamivirDibenzothiepinsHumansUnited StatesAcids, CarbocyclicIntracranial HemorrhagesZanamivirTriazinesMiddle AgedMaleGuanidinesMorpholinesPyridonesFemaleAdultAged

Stichwörter der Autor:innen

FAERSbaloxavir marboxilhemorrhageoseltamivirperamivirzanamivir

Substanzen

Antiviral AgentsperamivirbaloxavirOseltamivirDibenzothiepinsAcids, CarbocyclicZanamivirTriazinesGuanidinesMorpholines

Autor:innen und Institutionen

  • Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.
  • College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.

ORCID-Profile: Jyotirmoy Sarker, Todd A Lee

Zitieren

APA

Sarker, J., Carkovic, E., Ptaszek, K., & Lee, T. A. (2024). Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.2920

Vancouver

Sarker J, Carkovic E, Ptaszek K, Lee TA. Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2024. doi:10.1002/phar.2920

BibTeX
@article{Sarker2024,
  author = {Sarker, Jyotirmoy and Carkovic, Emir and Ptaszek, Karolina and Lee, Todd A},
  title = {Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2024},
  doi = {10.1002/phar.2920}
}
Kostenlos starten →